Evidence map›Paper›PMID 38408145›Full record

SynthesisCirculation2024

Outcomes After Aspirin Discontinuation Among Baseline Users in Contemporary Primary Prevention Aspirin Trials: A Meta-Analysis.

Ruth Campbell, Mark R Nelson, John J McNeill, John W McEvoy

Abstract readMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Circulation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Observational
  3. Article
  4. Article
  5. Review
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ruth CampbellNational Institute for Prevention and Cardiovascular Health and School of Medicine, University of Galway, Ireland (R.C., J.W.M.E.).
Mark R NelsonMenzies Institute for Medical Research, University of Tasmania, Hobart, Australia (M.R.N.).ORCID 0000-0001-9941-7161
John J McNeillDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia (M.R.N., J.J.M.N.).ORCID 0000-0002-1049-5129
John W McEvoyNational Institute for Prevention and Cardiovascular Health and School of Medicine, University of Galway, Ireland (R.C., J.W.M.E.).ORCID 0000-0001-6530-5479

Funding

ASPirin in Reducing Events in the ElderlyU01AG029824 · NIA · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI MCNEIL, JOHN JAMES, MURRAY, ANNE M · 2009 to 2018
$64.6M
Main Administrative CoreU19AG062682 · NIA · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI CHAN, ANDREW T, MCNEIL, JOHN JAMES · 2019 to 2023
$42.9M
NIA NIH HHS U01 AG029824NIA NIH HHS U19 AG062682
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AspirinCardiovascular DiseasesHumansPlatelet Aggregation InhibitorsPrimary PreventionResearch DesignRisk FactorsAspirinPlatelet Aggregation Inhibitorsaspirincardiovascular diseasesprimary prevention

Identifiers

PMID38408145
PMCPMC10901451

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.